PMID: 6159039Oct 1, 1980Paper

Plasma suppressive activity and kidney graft survival

The British Journal of Surgery
P S VeitchR M Taylor

Abstract

Over the past few years many centres have shown that blood transfusions given to potential renal transplant patients are beneficial to subsequent graft survival. Results from this centre have shown that an elevated ability of plasma to suppress lymphocyte reaction to antigen is associated with blood transfusions in chronic renal failure patients. In a prospective study, plasma suppressive activity was measured at the time of transplantation in 49 patients who were followed for between 3 and 15 months. Results showed that patients with a low level of plasma suppressive activity were at risk from early graft loss due to acute rejection. Furthermore, most of the suppressive activity was related to the naturally occurring plasma protein. alpha 2-macroglobulin. This prospective study reports a significant association between low plasma suppressive activity and early kidney graft loss through rejection, and suggests an explanation for the beneficial effects of blood transfusion on graft survival.

References

Oct 1, 1979·The British Journal of Surgery·G ProudB M Smith
Feb 1, 1978·Transplantation·J D BriggsD M Titterington
Nov 1, 1965·Transplantation·B A Barnes
Jan 1, 1959·Proceedings of the Society for Experimental Biology and Medicine·B B KAMRIN

❮ Previous
Next ❯

Citations

Mar 1, 1983·Veterinary Immunology and Immunopathology·O Barta
Jan 29, 1991·Biochimica Et Biophysica Acta·G L MurdockJ C Warren
Oct 17, 1981·Lancet·D M Francis, B K Shenton
Jan 1, 1983·Annals of the New York Academy of Sciences·D E Panrucker, F L Lorscheider
Oct 1, 1983·The British Journal of Surgery·P K DonnellyR M Taylor
Oct 1, 1985·The British Journal of Surgery·T W LennardR M Taylor
Apr 1, 1988·The British Journal of Surgery·S K SinghJ Jeekel
Apr 1, 1991·The British Journal of Surgery·A D ScottR K Phillips
Dec 1, 1986·The British Journal of Surgery·N R ParrottI D Johnston
Oct 1, 1984·Journal of Surgical Oncology·M M Nowak, J L Ponsky
Dec 2, 1993·International Journal of Cancer. Journal International Du Cancer·P J ClarkeK J Wood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.